Dongbang Medical Co., Ltd (KOSDAQ:240550)

South Korea · Delayed Price · Currency is KRW

6,050.00

-60.00 (-0.98%)

Jul 14, 2026, 3:30 PM KST

-52.21% (1Y)

Market Cap	126.65B -55.7%
Revenue (ttm)	117.37B +8.2%
Net Income	13.94B +275.2%
EPS	657.34 +205.6%
Shares Out	20.93M
PE Ratio	9.20
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	91,664
Open	6,000.00
Previous Close	6,110.00
Day's Range	5,810.00 - 6,240.00
52-Week Range	4,780.00 - 13,060.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Dongbang Medical

Dongbang Medical Co., Ltd produces and sells medical devices, fillers, bio medical devices, and cosmetics devices in South Korea. It offers HA filler, a medical device used for improving facial wrinkles and volume recovery under the ELASTY GRAND, ELASTY DEEP PLUS, ELASTY G PLUS, ELASTY D PLUS, and ELASTY F PLUS names; threads under the ELASTY LINE, ELASTY MESHFILL, ELASTY-V BARB, ELASTY-V UP, ELASTY-V SCREW, and ELASTY-V MONO names; and cannula, needle, and syringe products. The company also provides Hyaluronic acid mask, Beta-Glucan mask, FILL... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1985

Employees 282

Stock Exchange KOSDAQ

Ticker Symbol 240550

Full Company Profile

Financial Performance

In 2025, Dongbang Medical's revenue was 113.54 billion, an increase of 8.01% compared to the previous year's 105.11 billion. Earnings were 11.70 billion, an increase of 301.58%.

Financial Statements